These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 300712)

  • 1. Immunoreactivity to nuclear antigens in systemic lupus erythematosus with or without nephritis, and in other connective tissue diseases, with particular reference to the RNA-protein antigen.
    Mulli JC; Cruchaud A
    Int Arch Allergy Appl Immunol; 1977; 53(3):279-89. PubMed ID: 300712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibodies against various nuclear antigens (especially DNA and RNA proteins) in disseminated lupus erythematosus with and without kidney involvement and in other collagen diseases. Preliminary report].
    Mulli JC; Cruchaud A
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1724-5. PubMed ID: 1082642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
    Farber SJ; Bole GG
    Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation of antibodies to nuclear ribonucleoprotein (RNP) and nuclear acidic protein (Sm) with nephritis in patients with systemic lupus erythematosus (SLE).
    Kurata N; Hara I; Kinashi M; Akita H; Ofuji T
    Contrib Nephrol; 1978; 9():17-24. PubMed ID: 668385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD; Turner RA
    Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.
    Grennan DM; Bunn C; Hughes GR; Buchanan WW; Dick WC
    Ann Rheum Dis; 1977 Oct; 36(5):442-7. PubMed ID: 921344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-stranded DNA: an antigen of unique significance.
    Friou GJ
    J Lab Clin Med; 1978 Apr; 91(4):545-9. PubMed ID: 347010
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J
    Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of basophil sensitization by IgE antibodies to nuclear antigens in connective tissue diseases.
    Camussi G; Tetta C; Benveniste J
    Int Arch Allergy Appl Immunol; 1982; 69(4):358-62. PubMed ID: 6754627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a distinct nuclear acidic protein antigen (MA) and clinical findings in systemic lupus erythematosus patients with MA antibodies.
    Winn DM; Wolfe JF; Harmon D; Sharp GC
    J Clin Invest; 1979 Sep; 64(3):820-3. PubMed ID: 89119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinuclear antibodies in the immunotaxonomy of connective tissue diseases.
    Maini RN; Charles PJ; Venables PJ
    Scand J Rheumatol Suppl; 1985; 56():49-57. PubMed ID: 3873689
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of patients with serum antibodies to extractable nuclear antigens.
    Leibfarth JH; Persellin RH
    Arthritis Rheum; 1976; 19(5):851-6. PubMed ID: 786296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of a precipitin reaction to an RNA-protein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus.
    Reichlin M; Mattioli M
    N Engl J Med; 1972 Apr; 286(17):908-11. PubMed ID: 4622462
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis.
    Bresnihan B; Bunn C; Snaith ML; Hughes GR
    Br Med J; 1977 Mar; 1(6061):610-1. PubMed ID: 843832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephritis and the presence of antiribonucleoprotein antibodies in disseminated lupus erythematosus in children and adolescents].
    Lapointe ND; Carrenö-Perrez L; Pelletier M; Déom P; Robitaille P
    Union Med Can; 1985 Jun; 114(6):490-2. PubMed ID: 3875176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.